Cohance Lifesciences Limited
COHANCE
Rangering i aksjer
#6363
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Aksjekurs
$5.06
Markedsverdi
$1.93B
Endring (1 dag)
-1.34%
Endring (1 år)
-57.36%
Land
IN
Handel Cohance Lifesciences Limited (COHANCE)
Kategori
Healthcare
Markedsverdi av Cohance Lifesciences Limited(COHANCE)
Markedsverdi: $1.93B
Per October 2026 har Cohance Lifesciences Limited en markedsverdi på $1.93B. Dette gjør Cohance Lifesciences Limited til det 6363rd mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Cohance Lifesciences Limited fra 2020 til 2026
COHANCE sammenlignet med topp 5 mest populære stocks
